Benitec Biopharma Inc.
Develops ddRNAi gene therapies to silence genes causing chronic, life-threatening diseases.
BNTC | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 3940 TRUST WAY, 94545 HAYWARD
- Website:
- https://benitec.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the development and advancement of novel genetic medicines. The company utilizes its proprietary DNA-Directed RNA Interference (ddRNAi) therapeutic platform, which combines gene therapy with RNA interference (RNAi) to permanently silence disease-causing genes. This technology aims to create potentially curative, single-administration treatments. Benitec's pipeline targets chronic and life-threatening, gene-associated diseases for which there are currently no effective cures or therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Benitec Biopharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Benitec Biopharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Benitec Biopharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
